Ventas, Inc. (VTR) Stock

Real EstateREIT - Healthcare Facilities Website

VTR has an Alpha Score of 48 out of 100 (weak), computed on Nov 6, 2026 from 3 of 4 sub-scores. 14 members of Congress disclosed 25 trades in VTR since 2013: 11 purchases and 14 sales, most recently Alan Armstrong (purchase, Mar 27, 2026). 6 of the hedge funds AlphaScala tracks reported VTR in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Citadel's at $127.34M. Its trailing P/E ratio is 165.9 and its net margin 4.1% (key statistics as of Nov 4, 2026).

$89.04
-0.18%
Last price
Source: Finnhub
Alpha Score
48
Weak

What is VTR's Alpha Score?

How it works →

Alpha Score of 48 reflects weak overall profile with strong momentum, weak value, weak quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.

Momentum
71
Moderate
Value
36
Weak
Quality
49
Weak

Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.

Computed Nov 6, 2026

A rules-based research rating, not a recommendation to buy or sell.

Which members of Congress traded Ventas, Inc. (VTR)?

Members
14
Disclosed trades
25
Purchases
11
Sales
14

Most recent: Alan Armstrong (purchase, Mar 27, 2026); records start Dec 13, 2013.

PoliticianTrade dateTypeAmount
Alan Armstrong
R-OK · Senate
2026-03-27purchase$1k – $15k
Gil Cisneros
D-CA · House
2026-01-09partial sale$1k – $15k
Gil Cisneros
D-CA · House
2025-11-12purchase$1k – $15k
Earl Blumenauer
D-OR · House
2024-09-19sale$15k – $50k
Dan Goldman
D-NY · House
2023-07-14sale$1k – $15k
Dan Goldman
D-NY · House
2023-04-10sale$15k – $50k
Earl Blumenauer
D-OR · House
2022-03-14sale$1k – $15k
Earl Blumenauer
D-OR · House
2022-02-23purchase$15k – $50k

From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.

See all VTR political trades →

Which hedge funds own VTR?

From 13F filings
FundShares HeldPosition ValueChange vs prior Q
Citadel
Ken Griffin
1.43M$127.34M+162%
Marshall Wace622K$55.20M-19%
Renaissance Technologies
Jim Simons (founder)
618K$54.86M-24%
Point72
Steve Cohen
399K$35.40M+234%
D.E. Shaw
David Shaw
382K$33.91M-10%
Millennium Management
Israel Englander
97K$8.59MNEW

13F holdings as of Jun 30, 2026

Explore all tracked funds →

What are VTR's key statistics?

P/E Ratio
165.94
EPS (TTM)
0.55
Dividend Yield
3.99%
Beta
0.76
Net Margin
4.08%
ROE
1.94%
Debt / Equity
1.01
52W High
$101.60
52W Low
$72.66

Key statistics as of Nov 4, 2026

How does VTR's valuation compare with the Real Estate sector?

MetricVTRReal Estate medianCompanies in median
P/E ratio165.928.459
Net margin4.08%16.07%66
Return on equity1.94%7.15%67
Dividend yield (payers)3.99%4.33%54

Medians over the Real Estate stocks whose key statistics were refreshed in the last 35 days (newest Nov 6, 2026). P/E excludes loss-making companies.

VTR price chart

Powered by TradingView

What does Ventas, Inc. do?

Ventas Inc. is a leading real estate investment trust focused on seniors housing and healthcare properties across North America and the United Kingdom. It operates through three primary segments: the Senior Housing Operating Portfolio (SHOP), which owns and invests in senior housing communities in the United States and Canada; the Outpatient Medical and Research Portfolio (OM&R), dedicated to acquiring, developing, leasing, and managing outpatient medical buildings and research centers in the United States; and Triple-net Leased Properties (NNN), which invests in senior housing, skilled nursing facilities, long-term acute care facilities, freestanding inpatient rehabilitation facilities, and other healthcare properties in the United States and the United Kingdom. Ventas Inc. plays a vital role in the longevity economy by providing essential environments that support aging populations, including over 850 senior housing communities offering services for residents to thrive. Founded in 1983 and headquartered in Chicago, Illinois, the company leverages operational expertise to maintain a diversified portfolio of healthcare real estate assets.

CEO
Ms. Debra A. Cafaro J.D.
Employees
542
Market Cap
$43.60B
Ask about VTRAI research agent